Udayavni Special

ICMR, SII complete enrolment of phase-3 clinical trials for Covishield vaccine


Team Udayavani, Nov 12, 2020, 12:40 PM IST

New Delhi: The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.

The ICMR and SII have collaborated for the clinical development of Covovax developed by Novavax, US and upscaled by SII, a statement said.

“The partnership is a stellar example of private-public institutes collaborating to mitigate the dire consequences of the pandemic outbreak,” the ICMR said in the statement.

While the ICMR has funded the clinical trial site fees, SII has funded other expenses for Covishield.

At present, SII and ICMR are conducting phase 2/3 clinical trials of Covishield at 15 different centres across the country. It had completed the enrolment of all 1,600 participants on October 31.

“The promising results of the trials so far gives confidence that Covishield could be a realistic solution to the deadly pandemic. Covishield is by far the most advanced vaccine in human testing in India,” the ICMR said.

“Based on the phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India. SII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling license from DCGI,” the apex health research body said.

Covishield has been developed at SII Pune laboratory with a master seed from Oxford University/AstraZeneca.

The vaccine made in the United Kingdom is currently being tested in large efficacy trials in the UK, Brazil, South Africa and the US, the statement said.

Novavax has initiated its late phase trials in South Africa and in the UK and will soon commence the same in the US.

SII has received the bulk vaccine and Matrix-M adjuvant from Novavax and will soon fill and finish them in vials.

This vaccine formulated at SII (Covovax) will be tested in a phase 3 trial in India. An application for the same to regulatory authorities will be made soon by the ICMR and SII.

Commenting on the association, Adar Poonawalla, CEO of SII, world’s largest vaccine manufacturer by volume, said, “ICMR has played a huge role in coming forward and strengthening India’s fight against COVID-19. The collaboration will further aid us in putting India at the forefront of developing an immunogenic and efficacious vaccine.”

“The pandemic has presented a chance to foster structural reforms in building robust public healthcare infrastructure. The partnership further testifies the importance of private-public institutes coming together in scaling up the management and containing the spread of the virus,” he said.

Balram Bhargava, director general of ICMR said at present, India plays a prominent role in vaccine development and manufacturing globally.

Buoyed by the latest technology and well-equipped facilities, SII has continually proven its research and manufacturing prowess.

“The partnership is our contribution to lending our expertise and support to bolster our fight against the global pandemic,” he said.

The partnership will see scientists of both the entities facilitate the advancement of regulatory approvals for Covishield and Covovax while ensuring strict adherence to all the requisite scientific, ethical and regulatory standards.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Graffiti in support of terror groups: UTK demands immediate arrest of culprits

New farm laws have begun mitigating farmers’ problems in short span of time: PM

Barack Obama approves Drake to play him in a potential biopic

In BJP-RSS vision of India, Adivasis and Dalits should not have access to education: Rahul

K’taka State Election Comm starts voter list revision campaign

Delhi set to record coldest November in at least a decade: IMD data

COVID-19 caseload in India climbs to 93,92,919



Related Articles More

New farm laws have begun mitigating farmers’ problems in short span of time: PM

Pak violates ceasefire, targets forward posts, villages along IB in J-K’s Kathua

In BJP-RSS vision of India, Adivasis and Dalits should not have access to education: Rahul

Delhi set to record coldest November in at least a decade: IMD data

COVID-19 caseload in India climbs to 93,92,919

MUST WATCH

Meet the man with the largest collections of Newspapers | Umesh Rao Ekkar Mangalore

Mangalore: Woman rescues a cat from 30 feet deep well | Ranjini Shetty | Udayavani

CM and central leadership will take final call on Cabinet expansion: Ashwath Narayan

Assorted flowers, fruits, and vegetables are grown in the terrace garden

Celebrating 25 Years of Laveena Masala | Since 1996 | Udayavani

Latest Additions

Olympic-bound Sable breaks national half marathon record, first Indian to run it in less than 61 minutes

Graffiti in support of terror groups: UTK demands immediate arrest of culprits

Our government is in power because of those 17 people who joined BJP party: Laxman Sawadi, Deputy Chief Minister

Hardik Pandya bowls for first time in over a year

New farm laws have begun mitigating farmers’ problems in short span of time: PM

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.